Author Archives: Pharm Exec

Pharma Feels Impact of US Tax Inversion Legislation

The recent termination of AbbVie’s deal to acquire Shire has “jolted the industry out of its reverie” by becoming pharma’s first major casualty of new US tax inversion legislation,  says research and consulting firm GlobalData.
Posted in Deals, Europe, Global, Strategy | Tagged , , , | Leave a comment

US Healthcare Reform: A Pharm Exec Digest Special

This month’s special issue of Pharm Exec Global Digest looks at Dealing with the “side effects” of Obamacare The “value” of Rxs under Obamacare The escalating cost of US oncology care And more… Click here to read the issue.
Posted in Global, healthcare, Regulatory | Tagged , , , | Leave a comment

Cancer Medicines: Setbacks and Stepping Stones

A report released on this week by the Pharmaceutical Research and Manufacturers of America (PhRMA), “Researching Cancer Medicines: Setbacks and Stepping Stones,” highlights the number of investigational cancer medicines that did not succeed in clinical trials and how these so-called “failures” are a crucial part of the drug development process.
Posted in healthcare, R&D | Tagged , , , , | Leave a comment

Unlocking the True Value of Big Data: A Pharm Exec Global Digest Special

In this special issue of Pharm Exec Global Digest: Unlocking the true value of Big Data; Data privacy and the health sciences; In-silico modeling and real-word outcomes; and more… Click here to access the issue.
Posted in Strategy | Leave a comment

Jagged Little Pill: Drugs Through a Microneedle

By Randi Hernandez. Researchers at the Massachusetts Institute of Technology (MIT) have devised a novel drug capsule coated with tiny needles to deliver large-molecule biopharmaceuticals. This drug-delivery method would effectively prevent the breakdown of biologics in the stomach and inject the drug payload directly into the lining of the gastrointestinal (GI) tract. “This could be […]
Posted in Technology | Tagged , , | Leave a comment
  • Categories

  • Meta